Institut für Klinische Chemie und Laboratoriumsmedizin
Klinikum / Johannes Gutenberg-Universität Mainz
Forschungsprojekte
Ergebnisse pro Seite:
10
2023 - 2026
Cyclone 3 A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Abemaciclib in Combination with Abiraterone plus Prednisone in Men with High-Risk Metastatic Hormone-Sensitive Prostate Cancer- PD Dr. ReneMager,
- PD Dr. MaximilianBrandt
2022 - 2026
A Phase III Randomized, Open-Label, Multicenter Study to Determine the Efficacy and Safety of Durvalumab in Combination With Tremelimumab and Enfortumab Vedotin or Durvalumab in Combination With Enfortumab Vedotin for Perioperative Treatment in Patients Ineligible for Cisplatin or Who Refuse Cisplatin Undergoing Radical Cystectomy for Muscle InvasiveBladder Cancer (VOLGA)- PD Dr. med. MaximilianBrandt,
- PD Dr. ReneMager,
- Dr. AnitaThomas
2022 - 2024
A Randomized Open Label Phase 1/2 Study of INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared To Daratumumab SC, in Participants With Relapsed or Refractory Multiple Myeloma- Dr. med. MarkusMunder,
- Prof. Dr. med. GeorgHeß
2021 - 2029
ALLTogether1 – A Treatment study protocol of the ALLTogether Consortium for children and young adults (1-45 years of age) with newly diagnosed acute lymphoblastic leukaemia (ALL)- Univ.-Prof. Dr. med. JörgFaber,
- Dr. med. ArthurWingerter,
- Dr. med. AlexandraRusso
2018 - 2019
FORT-1:Phase 2/3 study of rogaratinib (BAY 1163877) vs chemotherapy in patients with FGFR-positive locally advanced or metastatic urothelial carcinoma- Prof. Dr. GeorgBartsch,
- Prof. Dr. IgorTsaur,
- PD Dr. ThomasHöfner
2018 - 2022
FORT-2: Phase 1b/2 study of rogaratinib (BAY 1163877) in combination with atezolizumab in urothelial carcinoma- Prof. Dr. GeorgBartsch,
- Prof. Dr. IgorTsaur,
- PD Dr. ThomasHöfner
2016 - 2017
Adapting conCLIP to illuminate the role of RNA-binding proteins (RBPs) in pathophysiological processes- Prof. Dr. SvenDanckwardt
2015 - 2017
Pathogenesis of the Antiphospholipid Syndrome- Dr. NadineMüller-Calleja,
- Univ.-Prof. Dr. KarlLackner